Markets Securities & Exchange Board
SEBI grants Nureca exemption from buyback rule during merger
This order grants Nureca Limited an exemption from a specific rule that normally prohibits announcing a share buyback while a merger scheme is pending.
SEBI allowed this because the merger involves only a wholly-owned subsidiary and does not change the public shareholding pattern.
Who it concerns: Nureca Limited (Transferee Company), Nureca Technologies Private Limited (Transferor Company/Wholly-owned subsidiary)
What SEBI found or ordered
- Exemption granted from sub-regulation (ii) of regulation 24 of the SEBI (Buy-back of Securities) Regulations, 2018.
- The exemption allows the company to announce a buyback despite the pendency of a Scheme of Arrangement (merger) with its wholly-owned subsidiary.
- SEBI determined the requirement was procedural in this specific context because there is no new issuance of equity shares or change in paid-up share capital.
- Conditions include that the buyback must comply with the Companies Act, 2013, and Buy-back Regulations, 2018.
- The exemption is limited to this specific application and does not operate as a precedent for other cases.
Also in the document
- The order is an exemption, not an enforcement action or penalty.
- SEBI noted that the merger is an internal restructuring of a wholly-owned subsidiary that does not affect public shareholders' holding percentages.
- The exemption was granted by Kamlesh C. Varshney, Whole Time Member, SEBI, on October 16, 2025.
How this was written
An AI model running on our own computer read the government document and wrote this summary. No person has checked it.
✓ Figures checked. Every number in this summary was found in the document by an automated check.
That check compares numbers only. It cannot confirm that the wording says what the document says — so the original document is always the authority.
The original document
Securities & Exchange Board of India (SEBI) — enforcement orders
Regulatory order · Ref. WTM/KCV/CFD/10 · 16 Oct 2025
Read it here
Discussion
No one has discussed this document yet.